Lista de obras - Yunda Huang - Dominio Público Uruguay

A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge

scientific article published on 01 September 2019

A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

artículo científico publicado en 2017

A case for preART-adjusted endpoints in HIV therapeutic vaccine trials

artículo científico publicado en 2016

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa

scientific article published on 23 April 2020

A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers

artículo científico publicado en 2011

Analysis of the Na,K-ATPase α- and β-subunit expression profiles of bladder cancer using tissue microarrays

article

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

artículo científico publicado en 2019

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

artículo científico publicado en 2020

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

artículo científico publicado en 2017

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

artículo científico publicado en 2003

China and HIV Vaccine Research: An Old Country with a New Commitment

article

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

scientific article published on 22 October 2020

Comparability and reproducibility of biomedical data ⬇️

artículo científico publicado el 27 de noviembre de 2012

Comparing and combining data across multiple sources via integration of paired‐sample data to correct for measurement error ⬇️

artículo científico publicado el 5 de julio de 2012

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma

artículo científico publicado en 2003

Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)

scientific article published on 01 June 2019

Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells

artículo científico publicado en 2011

Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials

artículo científico publicado en 2008

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

artículo científico publicado en 2016

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

artículo científico publicado en 2015

Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.

artículo científico publicado en 2004

Equivalence of ELISpot assays demonstrated between major HIV network laboratories

artículo científico publicado en 2010

Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)

artículo científico publicado en 2012

HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable

artículo científico publicado en 2011

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

artículo científico publicado en 2014

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

artículo científico publicado en 2011

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

artículo científico publicado en 2012

Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study

artículo científico publicado en 2014

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults

artículo científico publicado en 2017

Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

artículo científico publicado en 2020

In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide

artículo científico publicado en 2010

Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials

artículo científico publicado en 2020

Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa.

artículo científico publicado en 2018

New clinical trial designs for HIV vaccine evaluation

artículo científico publicado en 2013

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

artículo científico publicado en 2007

Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention

artículo científico publicado en 2022

P16-19. Statistical design and analysis of the CAVD-VIMC Elispot transfer study 001.

artículo científico publicado en 2009

Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults

artículo científico publicado en 2017

Power/sample size calculations for assessing correlates of risk in clinical efficacy trials

artículo científico publicado en 2016

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans

artículo científico publicado en 2011

Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials

artículo científico

Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma

artículo científico publicado en 2004

Reply to Richie and Villasante

artículo científico publicado en 2012

Robust antibody and cellular responses induced by DNA-only vaccination for HIV

artículo científico publicado en 2020

Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection

artículo científico publicado en 2007

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

scientific article published on 28 August 2019

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

artículo científico publicado en 2017

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

artículo científico publicado en 2016

Statistical methods for analyzing tissue microarray data

artículo científico publicado en 2004

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

artículo científico publicado en 2006

The sexually driven epidemic in youths in China's southwestern border region was caused by dynamic emerging multiple recombinant HIV-1 strains

artículo científico publicado en 2015

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects

artículo científico publicado en 2011

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

artículo científico publicado en 2014

Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1.

artículo científico publicado en 2011

Lista de obras de Yunda Huang

A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge

A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

A case for preART-adjusted endpoints in HIV therapeutic vaccine trials

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa

A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers

Analysis of the Na,K-ATPase α- and β-subunit expression profiles of bladder cancer using tissue microarrays

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

China and HIV Vaccine Research: An Old Country with a New Commitment

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Comparability and reproducibility of biomedical data ⬇️

Comparing and combining data across multiple sources via integration of paired‐sample data to correct for measurement error ⬇️

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma

Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)

Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells

Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.

Equivalence of ELISpot assays demonstrated between major HIV network laboratories

Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)

HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults

Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide

Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials

Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa.

New clinical trial designs for HIV vaccine evaluation

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention

P16-19. Statistical design and analysis of the CAVD-VIMC Elispot transfer study 001.

Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults

Power/sample size calculations for assessing correlates of risk in clinical efficacy trials

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans

Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials

Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma

Reply to Richie and Villasante

Robust antibody and cellular responses induced by DNA-only vaccination for HIV

Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

Statistical methods for analyzing tissue microarray data

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

The sexually driven epidemic in youths in China's southwestern border region was caused by dynamic emerging multiple recombinant HIV-1 strains

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1.